Sequana Medical announces positive data from non-randomized cohort in US Phase 1/2a …
… number of heart failure related rehospitalizations. About DSR, a disease-modifying heart failure drug therapy tackling cardiorenal syndrome (CRS).
… number of heart failure related rehospitalizations. About DSR, a disease-modifying heart failure drug therapy tackling cardiorenal syndrome (CRS).